Skip to main content
Fig. 1 | Perioperative Medicine

Fig. 1

From: Impact on grafted kidney function of rocuronium-sugammadex vs cisatracurium-neostigmine strategy for neuromuscular block management. An Italian single-center, 2014-2017 retrospective cohort case-control study

Fig. 1

Box plots comparing sugammadex to neostigmine on kidney function before and after surgery. Boxes represent the median and IQR. “Whiskers” (minimum and maximum marks) represent values 1.5 times the IQR [(1st quartile–1.5 × IQR) and (3rd quartile+1.5 × IQR)]. IQR interquartile range, p p value with significance set at < 0.05, NEO group of patients receiving neostigmine for reversal of cisatracurium-induced neuromuscular block (NMB), SUG group of patients receiving sugammadex for reversal of rocuronium-induced NMB, PRE baseline value (before kidney transplantation), POST first measurement obtained the day of kidney transplantation, creatinine and urea serum creatinine and serum urea, eGRF estimated glomerular filtration rate

Back to article page